Table 1.
Clinical characteristics of HT samples.
| Control | HT | P-value | |
|---|---|---|---|
| N = 24 | N = 24 | ||
| F | 19 | 23 | |
| M | 5 | 1 | |
| Age (years) | 48.54 ± 11.67 | 41.38 ± 12.98 | 0.050 |
| BMI (kg/m2) | 22.42 ± 3.40 | 23.03 ± 2.31 | 0.554 |
| FT3 (pmol/l) | 4.86 ± 0.81 | 9.76 ± 11.07* | 0.041 |
| FT4 (pmol/l) | 14.89 ± 5.11 | 25.83 ± 26.16 | 0.055 |
| TSH (MIU/l) | 1.96 ± 0.98 | 4.32 ± 8.38 | 0.183 |
| TPOAb (IU/ml) | 10.26 ± 7.06 | 408.10 ± 238.75*** | <0.001 |
| TGAb (IU/ml) | 21.43 ± 29.12 | 982.32 ± 1194.77** | 0.001 |
| TRAb (IU/L) | 1.82 ± 4.38 | 3.07 ± 4.32 | 0.464 |
HT, Hashimoto’s thyroiditis; F, female; M, male; BMI, body mass index; FT3, free triiodothyronine; FT4, free thyroxine; TSH, thyroid-stimulating hormone; TRAb, thyrotropin receptor antibody; TGAb, anti-thyroglobulin antibody; TPOAb, thyroid peroxidase antibody.
Plus–minus values are means ± SD.
*P < 0.05, **P < 0.01, ***P < 0.001.